Russia’s Enteromix cancer vaccine, developed using mRNA technology, has shown 100 percent efficacy in early trials. Not yet approved for clinical use, it offers a personalised approach to training the immune system to target cancer cells
This is very hopeful news. All cancer sucks but colorectal is on both sides of my gene pool and it scares me that I’m not eligible for a colonoscopy until I’m 50 where I live.
This is very hopeful news. All cancer sucks but colorectal is on both sides of my gene pool and it scares me that I’m not eligible for a colonoscopy until I’m 50 where I live.